Ubs Asset Management Americas Inc Lannett CO Inc Transaction History

Ubs Asset Management Americas Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$6.43 - $9.86 $46,289 - $70,982	-7,199 Reduced 29.49%	17,215 $124,000
Q1 2020 May 15, 2020	BUY	$6.36 - $10.05 $22,571 - $35,667	3,549 Added 17.01%	24,414 $169,000
Q4 2019 Feb 14, 2020	BUY	$8.49 - $12.81 $177,143 - $267,280	20,865 New	20,865 $184,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.